Table 6.
Excess relative risk estimates for all solid cancer incidence by calendar period or age at exposure under linear-quadratic dose-response model: LSS, 1958–2009
| Calendar period | Age at bombing | ||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Year | Cases | Q/L | P a | Year | Cases | Q/L | P a |
| 95% CI | 95% CI | ||||||
| Males | Males | ||||||
| 1958–1987 | 4,878 | 2.34b | 0.031 | 20–83 | 5,628 | 0.16 | 0.891 |
| ≤−1.25 or ≥0.12 | Undefined | ||||||
| 1988–2009 | 5,595 | 1.52 | 0.022 | 0–19 | 4,845 | 2.43 | <0.001 |
| ≤−3.16 or ≥0.13 | ≤−3.23 or ≥0.33 | ||||||
| Pc | 0.845 | 0.258 | |||||
| Females | Females | ||||||
| 1958–1987 | 6,053 | 0.04 | 0.850 | 20–83 | 8,220 | −0.02 | 0.573 |
| −0.14 to 0.40 | −0.21 to 0.41 | ||||||
| 1988–2009 | 6,012 | 0.23 | 0.373 | 0–19 | 3,845 | 0.20 | 0.273 |
| −0.07 to 1.06 | −0.05 to 0.75 | ||||||
| Pc | 0.388 | 0.294 | |||||
Note. LSS, Life Span Study. ERR, excess relative risk. L, linear dose coefficient. Q, quadratic dose coefficient. Q/L, ratio of quadratic to linear dose coefficient or curvature. 95% CI, confidence interval.
P value for quadratic departure from linearity.
Curvature estimates are from linear-quadratic ERR models with parametric background (common to both calendar periods or ages at exposure), multiplicative adjustment for smoking, independent effect modification by sex, sex-specific attained age, age at exposure, and high dose.
P value for heterogeneity in sex-specific curvature by calendar period or age at exposure.